IBEX 35
10.992,30 -73,80 (-0,67%) Euro Stoxx 50
4.839,14 -96,36 (-1,95%) Dólar/Euro
1,0709 -0,0033 (-0,31%) Petróleo Brent
82,60 -0,15 (-0,18%) Oro
2.348,40 +30,40 (+1,31%) Bitcoin EUR
61.668,44 -100,15 (-0,16%)
Cisen Pharmaceutical Co., Ltd. (603367.SS)
Cisen Pharmaceutical Co., Ltd.
No. 16 Tongji Road
High-tech Zone
Jining 272073
China
86 53 7298 9199
https://www.lkcisen.com
Sector(es): Healthcare
Sector: Drug Manufacturers - Specialty & Generic
Empleados a tiempo completo: 3402
Ejecutivos clave
| Nombre | Título | Paga | Ejecutado | Año de nacimiento |
|---|---|---|---|---|
| Mr. Zhenxin Du | Chairman, GM & CFO | N/A | N/A | 1967 |
| Ms. Xiu Lian Lu | Deputy GM & Director | N/A | N/A | 1967 |
| Mr. Liushan Hao | Deputy GM & Director | N/A | N/A | 1970 |
Descripción
Cisen Pharmaceutical Co., Ltd., together with its subsidiaries, manufactures and sells chemical drug preparations and health care products in China and internationally. The company's chemical drug preparations include liver disease drugs, antitumor and auxiliary drugs, nutrition preparations, contrast agents, antibiotics, digestive system agents, polypropylene ampoules, and external preparations, as well as sedation anesthesia, cardiovascular, cough and asthma, immunomodulator, infusion, and therapeutic infusion products. The company was formerly known as Shandong Lukang Cisen Pharmaceutical Co., Ltd. and changed its name to Cisen Pharmaceutical Co., Ltd. in 2011. Cisen Pharmaceutical Co., Ltd. was founded in 1998 and is headquartered in Jining, the People's Republic of China.
Gobierno corporativo
El ISS Governance QualityScore de Cisen Pharmaceutical Co., Ltd., a día N/A, es N/A. Las puntuaciones base son Auditoría: N/A; Tablero: N/A; Derechos de los accionistas: N/A; Compensación: N/A.
